Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Moderna

Market Cap: US$9.9b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Recursion Pharmaceuticals

Market Cap: US$2.1b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

AbCellera Biologics

Market Cap: US$1.5b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Voronoi

Market Cap: ₩2.9t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

Mesoblast

Market Cap: AU$3.0b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Yuhan

Market Cap: ₩8.9t

Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.

Daewoong Pharmaceutical

Market Cap: ₩1.5t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

Telix Pharmaceuticals

Market Cap: AU$4.9b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Acutaas Chemicals

Market Cap: ₹107.9b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Semnur Pharmaceuticals

Market Cap: US$5.6b

Develops and markets non-opioid drugs to treat back pain.